Components of a randomized clinical trial

Journal of Periodontal Research

Volumn 32, Issue 5, 1997, Pages 430-438

  Dennison, David K ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Ethics; Informed consent; Institutional review board; Randomized clinical trial

Indexed keywords

PLACEBO;

AGED; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLASSIFICATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DEMOGRAPHY; DRUG CONTRAINDICATION; EMPLOYMENT; FEMALE; HUMAN; INFORMED CONSENT; MALE; MEDICAL ETHICS; MENTAL DISEASE; METHODOLOGY; PATIENT ADVOCACY; PATIENT EDUCATION; PATIENT SELECTION; PERSUASIVE COMMUNICATION; POVERTY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SAMPLE SIZE; STANDARD; STUDENT; TREATMENT OUTCOME;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

AGED; CLINICAL PROTOCOLS; COERCION; CROSS-OVER STUDIES; DEMOGRAPHY; EMPLOYMENT; ETHICS, DENTAL; FEMALE; HUMANS; INFORMED CONSENT; MALE; MENTAL DISORDERS; PATIENT ADVOCACY; PATIENT EDUCATION; PATIENT SELECTION; PLACEBOS; POVERTY; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RISK FACTORS; SAMPLE SIZE; STUDENTS; TREATMENT OUTCOME;

EID: 0031179438     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1997.tb00555.x     Document Type: Article

References (24)

1. Fried C. Medical Experimentation: personal integrity and social policy. New York: American Elsevier Company, 1974.
2. Hill AB. Medical ethics and controlled trials. Br Med J 1963: 1: 1043-1049.
3. Chalmers TC, Block JB, Lee S. Controlled studies in clinical cancer research N Engl J Med 1972; 287: 75-78.
4. Levine RJ. Ethics and Regulation of Clinical Research, 2nd edn. Baltimore and Munich: Urban & Schwarzenberg, 1986.
5. Shaw LW, Chalmers TC. Ethics in cooperative trials. Ann NY Acad Sci 1970; 169: 487-495.
6. Freedman B. Equipoise and the ethics of clinical research. N Eng J Med 1987; 317: 141-145.
7. Lasagna L. Drug evaluation problems in academic and other contexts. Ann NY Acad Sci 1970; 169: 503-508.
8. Food and Drug Administration. General Considerations for the Clinical Evaluation of Drugs. DHEW Publication No. (FDA) 77-3040, Washington, 1978.
9. Freireich EJ, Gehan EA. The limitations of the randomized clinical trial. In: DeVita Jr VT, Busch H, eds. Methods in Cancer Research: cancer drug development, vol XVII, Part B. New York: Academic Press, 1979; pp. 277-310.
10. Rutstein DD. The ethical design of human experiments. In: Freund PA, ed. Experimentation with Human Subjects New York: George Braziller, 1970; pp. 383-401.
11. McCartney JJ. Encephalitis and Ara A: an ethical case study. Hastings Center Rep 1978: 8: 5-7.
12. Whitley RJ, Alford CA. Encephalitis and adenine arabinoside: an indictment without fact. Hastings Center Rep 1979; 9: 4, 44-46.
13. Levine RJ, Lebacqz K. Some ethical considerations in clinical trials. Clin Pharmacol Therap 1979; 25: 728-741.
14. Chalmers TC, Celano P, Sacks HS. Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983; 309: 1358-1361.
15. Ellenberg SS. Randomization designs in comparative clinical trials. N Engl J Med 1984; 310: 1404-1408.
16. Levine C, Dubler NN, Levine RJ. Building a new consensus: ethical principles and policies for clinical research on HIV/AIDS. IRB: Rev Human Subjects Res 1991; 13: 1-17.
17. Cassileth RB, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA 1982; 248: 968-970.
18. Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: the patient's point of view. Controll Clin Trials 1985; 5: 156-167.
19. Cowan DH. Scientific design, ethics and monitoring: IRB review of randomized clinical trials. IRB: Rev Human Subjects Res 1980; 2: 1-4.
20. Veatch RM. Longitudinal studies, sequential design and grant renewals: what to do with preliminary data. IRB: Rev Human Subjects Res 1979; 1: 1-3.
21. Friedman L, Demets D. The Data Monitoring Committee: how it operates and why. IRB. Rev Human Subjects Res 1981; 3. 6-8.
22. Schafer A. The ethics of the randomized clinical trial. N Engl J Med 1982; 307: 719-724.
23. Marquis D. Leaving therapy to chance. Hastings Center Rep 1983; 13: 40-47.
24. Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer: report after ten years of a clinical trial. Br Med J 1972; 2: 423-429.